Accelerating Science: The people and technologies changing the world >

Biomarker testing service by Drug Development Solutions

Manufacturer Drug Development Solutions  |  Available Worldwide
DDS's expert biomarker teams support non-clinical and clinical biomarker method development, validation and sample analysis. DDS's capabilities span from measuring single to multiple analyte profiles, such as those employed to monitor cytokine storms.

Biomarker testing service by Drug Development Solutions product image
Biomarker testing service
Request Pricing

Receive your quote directly from the manufacturer.

0 Scientists have reviewed this product

Write the First Review

No Reviews

DDS have a wealth of experience in detection and quantitation of biomarkers in a wide variety of matrices. 

More than 200 dedicated scientists work in one the world’s largest bioanalytical facilities with a broad range of analytical platform.

DDS's biomarker services can be adapted to your specific requirements:

  • Assay development
  • Validation
  • Quantification 
  • Capacity
  • Methods and instrumentation

DDS have extensive experience with a range of biomarkers, including those linked to:

  • Target engagement
  • Coagulation cascade
  • Diabetes
  • GI disorders
  • Inflammatory diseases
  • Neurological disorders
  • Oncology
  • Respiratory diseases
  • Endocrinology
  • Renal disease/damage
  • Stress management

DDS have a range of analytical platforms for DDS's biomarker methodologies, using both ligand binding assays, flow cytometry and mass spectrometry, in a multitude of matrix types:

  • Blood/serum/plasma
  • Peripheral blood cells
  • BALF
  • Sputum
  • Bone marrow
  • Solid tumours
  • FFPE
  • CSF
  • Saliva
  • Synovial fluid
  • Urine
  • Sweat
  • Tears
  • Breast milk

Analytical platforms

  • Quanterix® HD-X analyser
  • Sciex TripleTOF® 6600 LC-MS
  • Gyrolab® xP
  • LC-MS
  • MSD®
  • Luminex MAGPIX®
  • Envision
  • Beckman Coulter CytoFLEX
  •  Randox Daytona+